Tanzania - English - Tanzania Medicinces & Medical Devices Authority

abacus parenteral drugs limited, uganda - calcium chloride bp , sodium chloride bp , potassium chloride bp , sodium lactate usp - solution for infussion - sodium lactate b.p 0.320% w/v,sodium chloride b.p. 0.600 % w/v,potassium chloride b.p 0.040 % w/v,calcium chloride dihydrate b.p. 0.027 % w/v

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

baxter healthcare pty ltd - calcium chloride; potassium chloride; sodium lactate; sodium chloride - parenteral liquid/solution/suspension - calcium chloride mineral-calcium-salt active 0.27 g/l; potassium chloride mineral-potassium active 0.4 g/l; sodium lactate mineral-sodium active 3.22 g/l; sodium chloride mineral-sodium-salt active 6.0 g/l - nutrition & metabolism - all animals - dehydration | electrolyte replacement

Israel - English - Ministry of Health

teva medical marketing ltd. - sodium chloride - solution for infusion - sodium chloride 0.9 %w/v - sodium chloride - sodium chloride - treatment of isotonic extracellular dehydration. treatment of sodium depletion. vehicle or diluent of compatible drugs for parenteral administration.

Israel - English - Ministry of Health

teva medical marketing ltd. - sodium chloride - solution for infusion - sodium chloride 0.9 %w/v - sodium chloride - sodium chloride - treatment of isotonic extracellular dehydration. treatment of sodium depletion. vehicle or diluent of compatible drugs for parenteral administration.

Israel - English - Ministry of Health

teva medical marketing ltd. - calcium chloride dihydrate; potassium chloride; sodium chloride; sodium lactate - solution for infusion - sodium lactate 0.32 %w/v; calcium chloride dihydrate 0.027 %w/v; potassium chloride 0.04 %w/v; sodium chloride 0.6 %w/v - calcium chloride - calcium chloride - source of water and electrolytes. regulation or maintenance of metabolic acidosis ( except lactic acidosis).

United States - English - NLM (National Library of Medicine)

aspen veterinary - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb, chloride ion - unii:q32zn48698), sodium lactate (unii: tu7hw0w0qt) (sodium cation - unii:lyr4m0nh37, lactic acid - unii:33x04xa5at) - lactated ringer injection is indicated as a source of water and electrolytes for all species. it is also used as an alkalinizing agent. lactated ringer injection is contraindicated in patients with a known hypersensitivity to sodium lactate; congestive heart failure or severe impairment of renal function; clinical states in which the administration of sodium and chloride is detrimental.

United States - English - NLM (National Library of Medicine)

hf acquisition co llc, dba healthfirst - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), sodium lactate (unii: tu7hw0w0qt) (sodium cation - unii:lyr4m0nh37, lactic acid, unspecified form - unii:33x04xa5at), calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb, chloride ion - unii:q32zn48698), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698) - these solutions are indicated for parenteral replacement of extracellular losses of fluid and electrolytes, with or without minimal carbohydrate calories, as required by the clinical condition of the patient. solutions containing lactate are not for use in the treatment of lactic acidosis. to open: tear outer wrap at notch and remove solution container. if supplemental medication is desired, follow directions below before preparing for administration. some opacity of the plastic due to moisture absorption during the sterilization process may be observed. this is normal and does not affect the solution quality or safety. the opacity will diminish gradually. to add medication prepare additive port. using aseptic technique and an additive delivery needle of appropriate length, puncture resealable additive port at target area, inner diaphragm and inject. withdraw needle after injecting medication. the additive port may be protected by covering with an additive cap. mix container contents thoroughly. preparation for administration (use aseptic technique) close flow control clamp of administration set. remove cover from outlet port at bottom of container. insert piercing pin of administration set into port with a twisting motion until the set is firmly seated. note: see full directions on administration set carton. suspend container from hanger. squeeze and release drip chamber to establish proper fluid level in chamber. open flow control clamp and clear air from set. close clamp. attach set to venipuncture device. if device is not indwelling, prime and make venipuncture. regulate rate of administration with flow control clamp. warning: do not use flexible container in series connections.

United States - English - NLM (National Library of Medicine)

fresenius kabi usa, llc - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), sodium lactate (unii: tu7hw0w0qt) (sodium cation - unii:lyr4m0nh37, lactic acid, unspecified form - unii:33x04xa5at), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb, chloride ion - unii:q32zn48698), dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl - these solutions are indicated for parenteral replacement of extracellular losses of fluid and electrolytes, with minimal carbohydrate calories, as required by the clinical condition of the patient. solutions containing lactate are not for use in the treatment of lactic acidosis. check flexible container solution composition, lot number, and expiry date. do not remove solution container from its overwrap until immediately before use. use sterile equipment and aseptic technique. flexible plastic container (free flex ® bag) to open - turn solution container over so that the text is face down. using the pre-cut corner tabs, peel open the overwrap and remove solution container. - check the solution container for leaks by squeezing firmly. if leaks are found, or if the seal is not intact, discard the solution. - do not use if the solution is cloudy or a precipitate is present. to add medication - identify white additive port with arrow pointing toward container. - immediately before injecting additives, break off

United States - English - NLM (National Library of Medicine)

b. braun medical inc. - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), sodium lactate (unii: tu7hw0w0qt) (lactic acid - unii:33x04xa5at, sodium cation - unii:lyr4m0nh37), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb, chloride ion - unii:q32zn48698) - this solution is indicated for use in adults and pediatric patients as a source of electrolytes and water for hydration. the use of lactated ringer’s injection usp is contraindicated in neonates (28 days of age or younger) receiving concomitant treatment with ceftriaxone, even if separate infusion lines are used, due to the risk of fatal ceftriaxone-calcium salt precipitation in the neonate’s bloodstream [see warnings, drug interactions, pediatric use ]. this solution is contraindicated where the administration of sodium, potassium, calcium, lactate, or chloride could be clinically detrimental. lactate administration is contraindicated in severe metabolic acidosis or alkalosis, and in severe liver disease or anoxic states which affect lactate metabolism.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty limited - calcium chloride; sodium lactate; potassium chloride; sodium chloride -